Announcements Trials
Browse Landscape

Phase

Phase NA 69Phase 2 69Phase 3 21Phase 1 15Phase 1/2 12Phase 2/3 4Phase 4 3Phase EARLY_PHASE1 2

Status

Completed 24Terminated 11Recruiting 10Active not recruiting 6Not yet recruiting 4Withdrawn 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Interventions

Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Brain Neoplasms × Clear all
NCT05459441 2022-07-15

Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases

Shanghai Pudong Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
CNS

Brain Neoplasms, Glioma

NCT04967027 2022-03-02

Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain Metastases

Xiangya Hospital of Central South University

Phase EARLY_PHASE1 Unknown
5 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡